Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 233

1.

Novel high-sensitive D-dimer determination predicts chemotherapy-associated venous thromboembolism in intermediate risk lung cancer patients.

Ferroni P, Martini F, Portarena I, Massimiani G, Riondino S, La Farina F, Mariotti S, Guadagni F, Roselli M.

Clin Lung Cancer. 2012 Nov;13(6):482-7. doi: 10.1016/j.cllc.2012.03.005. Epub 2012 May 15.

PMID:
22591606
2.

Multicenter evaluation of a new quantitative highly sensitive D-dimer assay, the Hemosil D-dimer HS 500, in patients with clinically suspected venous thromboembolism.

Legnani C, Cini M, Scarvelis D, Toulon P, Wu JR, Palareti G.

Thromb Res. 2010 May;125(5):398-401. doi: 10.1016/j.thromres.2009.07.013. Epub 2009 Aug 15.

PMID:
19683797
3.

D-dimer and prothrombin fragment 1 + 2 predict venous thromboembolism in patients with cancer: results from the Vienna Cancer and Thrombosis Study.

Ay C, Vormittag R, Dunkler D, Simanek R, Chiriac AL, Drach J, Quehenberger P, Wagner O, Zielinski C, Pabinger I.

J Clin Oncol. 2009 Sep 1;27(25):4124-9. doi: 10.1200/JCO.2008.21.7752. Epub 2009 Jul 27.

4.

Early changes of a novel APC-dependent thrombin generation assay during chemotherapy independently predict venous thromboembolism in cancer patients--a pilot study.

Ferroni P, Martini F, Portarena I, Grenga I, Riondino S, La Farina F, Laudisi A, Guadagni F, Roselli M.

Support Care Cancer. 2012 Nov;20(11):2713-20. doi: 10.1007/s00520-012-1391-1. Epub 2012 Feb 10.

PMID:
22322591
6.

Preoperative plasma D-dimer predicts 1-year survival in colorectal cancer patients with absence of venous thromboembolism (VTE): a prospective clinical cohort study.

Stender MT, Larsen TB, Sørensen HT, Thorlacius-Ussing O.

J Thromb Haemost. 2012 Oct;10(10):2027-31. doi: 10.1111/j.1538-7836.2012.04887.x.

7.

Therapeutic significance of a D-dimer cut-off level of >3 µg/ml in colorectal cancer patients treated with standard chemotherapy plus bevacizumab.

Mochizuki S, Yoshino T, Kojima T, Fuse N, Ikematsu H, Minashi K, Yano T, Tahara M, Kaneko K, Doi T, Koike K, Ohtsu A.

Jpn J Clin Oncol. 2010 Oct;40(10):933-7. doi: 10.1093/jjco/hyq058. Epub 2010 May 21.

8.

Diagnostic accuracy of the Triage D-dimer test for exclusion of venous thromboembolism in outpatients.

Ghys T, Achtergael W, Verschraegen I, Leus B, Jochmans K.

Thromb Res. 2008;121(6):735-41. Epub 2007 Sep 20.

PMID:
17888501
9.

The predictive characteristics of D-dimer testing in outpatients with suspected venous thromboembolism: a Bayesian approach.

Risch L, Monn A, Lüthy R, Honegger H, Huber AR.

Clin Chim Acta. 2004 Jul;345(1-2):79-87.

PMID:
15193980
10.

Preoperative plasma D-dimer levels predict survival in patients with operable non-small cell lung cancer independently of venous thromboembolism.

Zhang PP, Sun JW, Wang XY, Liu XM, Li K.

Eur J Surg Oncol. 2013 Sep;39(9):951-6. doi: 10.1016/j.ejso.2013.06.008. Epub 2013 Jun 28.

PMID:
23810331
11.

D-dimer before chemotherapy might predict venous thromboembolism.

Arpaia G, Carpenedo M, Verga M, Mastrogiacomo O, Fagnani D, Lanfredini M, Milani M, Cimminiello C.

Blood Coagul Fibrinolysis. 2009 Apr;20(3):170-5. doi: 10.1097/MBC.0b013e32831bc2de.

PMID:
19276795
12.

Clinical analysis of postoperative venous thromboembolism risk factors in lung cancer patients.

Yang Y, Zhou Z, Niu XM, Li ZM, Chen ZW, Jian H, Ai XH, Cheng BJ, Liao ML, Lu S.

J Surg Oncol. 2012 Nov;106(6):736-41. doi: 10.1002/jso.23190. Epub 2012 Jun 18.

PMID:
22711667
13.

Risk of recurrence in patients with pulmonary embolism: predictive role of D-dimer and of residual perfusion defects on lung scintigraphy.

Poli D, Cenci C, Antonucci E, Grifoni E, Arcangeli C, Prisco D, Abbate R, Miniati M.

Thromb Haemost. 2013 Feb;109(2):181-6. doi: 10.1160/TH12-07-0534. Epub 2012 Nov 29.

PMID:
23196319
14.

Prognostic significance of elevated D-dimer for survival in patients with sarcoma.

Raj SD, Zhou X, Bueso-Ramos CE, Ravi V, Patel S, Benjamin RS, Vadhan-Raj S.

Am J Clin Oncol. 2012 Oct;35(5):462-7.

PMID:
21654313
15.

Combined use of pretest clinical probability score and latex agglutination D-dimer testing for excluding acute deep vein thrombosis.

Yamaki T, Nozaki M, Sakurai H, Kikuchi Y, Soejima K, Kono T, Hamahata A, Kim K.

J Vasc Surg. 2009 Nov;50(5):1099-105. doi: 10.1016/j.jvs.2009.06.059. Epub 2009 Aug 22.

16.

High plasma D-dimer level is associated with decreased survival in patients with lung cancer.

Altiay G, Ciftci A, Demir M, Kocak Z, Sut N, Tabakoglu E, Hatipoglu ON, Caglar T.

Clin Oncol (R Coll Radiol). 2007 Sep;19(7):494-8. Epub 2007 May 21.

PMID:
17513096
17.

Predictive value of D-dimer test for recurrent venous thromboembolism after anticoagulation withdrawal in subjects with a previous idiopathic event and in carriers of congenital thrombophilia.

Palareti G, Legnani C, Cosmi B, Valdré L, Lunghi B, Bernardi F, Coccheri S.

Circulation. 2003 Jul 22;108(3):313-8. Epub 2003 Jul 7.

18.

Risk of venous thromboembolism in patients with borderline quantitative D-dimer levels.

Taira T, Taira BR, Carmen M, Chohan J, Singer AJ.

Am J Emerg Med. 2010 May;28(4):450-3. doi: 10.1016/j.ajem.2009.01.023.

PMID:
20466224
19.

Age and gender specific cut-off values to improve the performance of D-dimer assays to predict the risk of venous thromboembolism recurrence.

Legnani C, Cini M, Cosmi B, Carraro P, Tripodi A, Erba N, Palareti G.

Intern Emerg Med. 2013 Apr;8(3):229-36. doi: 10.1007/s11739-011-0608-5. Epub 2011 May 17.

PMID:
21584847
20.

Predictive value of D-dimer test for recurrent venous thromboembolism at hospital discharge in patients with acute pulmonary embolism.

Wang Y, Liu ZH, Zhang HL, Luo Q, Zhao ZH, Zhao Q.

J Thromb Thrombolysis. 2011 Nov;32(4):410-6. doi: 10.1007/s11239-011-0625-2.

PMID:
21847593
Items per page

Supplemental Content

Write to the Help Desk